SL
DXCM icon

Salomon & Ludwin’s DexCom DXCM Stock Holding History

Salomon & Ludwin’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.7K Sell
269
-9
-3% -$627 ﹤0.01% 1214
2025
Q4 		$18.8K Buy
278
+6
+2% +$388 ﹤0.01% 949
2025
Q3 		$18.2K Buy
272
+68
+33% +$5.38K ﹤0.01% 873
2025
Q2 		$17.1K Buy
204
+160
+364% +$12.5K ﹤0.01% 412
2025
Q1 		$3K Hold
44
– – ﹤0.01% 556
2024
Q4 		$3.42K Hold
44
– – ﹤0.01% 540
2024
Q3 		$2.95K Buy
+44
New +$3.61K ﹤0.01% 573
2020
Q2 		– Sell
-520
Closed -$35K – 112
2020
Q1 		$35K Buy
+520
New +$32.4K 0.01% 108

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Salomon & Ludwin's DXCM Position: Q1 2026 in Review

Salomon & Ludwin reduced its DexCom (DXCM) stake by 3.2% in Q1 2026, selling an estimated $627 and leaving 269 shares worth $16.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1214.

Salomon & Ludwin first reported a position in DXCM in Q1 2020 and has held it in 8 quarters since. The position peaked at $35K in Q1 2020. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Salomon & Ludwin held 269 shares of DexCom worth $16.7K as of Q1 2026.
  • Salomon & Ludwin sold 9 DexCom shares in Q1 2026, an estimated $627.
  • DexCom made up ﹤0.01% of Salomon & Ludwin's portfolio in Q1 2026, its #1214 holding.
  • Salomon & Ludwin first reported a position in DexCom in Q1 2020 and has held it in 8 quarters since.
  • Salomon & Ludwin's DexCom position peaked at $35K in Q1 2020.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Salomon & Ludwin's 13F filing for Q1 2026, filed 11 May 2026.